🔎 Trials Near Me

Home › Cancro colorettale › Georgia

Studi clinici su Cancro colorettale nello stato di Georgia

38 studi su Cancro colorettale cercano partecipanti presso sedi nello stato di Georgia.

Città nello stato di Georgia

Testo ufficiale dello studio (inglese)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  • Grady Health System, Atlanta
  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • e altri 2
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05673148

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Winship Cancer Institute of Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Northeast Georgia Medical Center Braselton, Braselton
  • Atlanta VA Medical Center, Decatur
  • Northeast Georgia Medical Center-Gainesville, Gainesville
  • e altri 4
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • University Cancer & Blood Center, LLC, Athens
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07222800

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  • Emory University School of Medicine, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06004245

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  • University Cancer And Blood Center LLC, Athens
  • Grady Memorial Hospital, Atlanta
  • Piedmont Cancer Institute, Atlanta
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06750094

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

  • City of Hope Atlanta Cancer Center, Newnan
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07271355

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  • Grady Memorial Hospital, Atlanta
  • Winship Cancer Institute Emory University, Atlanta
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT05863195

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  • Local Institution - 0326, Atlanta
  • Northside Hospital, Atlanta
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital, Marietta
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07221357

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Emory University School of Medicine - Winship Cancer Institute, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07114601

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • Piedmont Cancer Institute, Locust Grove
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07284849

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07147231

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

  • Clinical Study Site, Atlanta
  • Clinical Study Site, Atlanta
  • Clinical Study Site, Newnan
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07228832

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06400472

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

  • Emory Winship Cancer Institute, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT07321106

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
In reclutamentoFase 1/2
12 Months – 30 Years · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04851119

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

  • Emory University School of Medicine, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT06586515

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

  • City of Hope Atlanta Cancer Center, Newnan
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 ago 2026 · NCT07125729

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

  • Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 lug 2026 · NCT07094113

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • Emory University, Atlanta
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT03526835

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital, Atlanta
  • Winship Cancer Institute, Atlanta
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT05253651

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  • Winship Cancer Center - Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 lug 2026 · NCT06657144

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

  • Piedmont Healthcare Inc., Atlanta
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 lug 2026 · NCT06937177

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

  • Emory University, Atlanta
In reclutamentoFase 4
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 lug 2026 · NCT06562543

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

  • Winship Cancer Institute at Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT07094204

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Piedmont Healthcare, Atlanta
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 mag 2026 · NCT05379985

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
  • e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 apr 2026 · NCT07405476

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

  • Augusta University Medical Center, Augusta
  • Northeast Georgia Medical Center Braselton, Braselton
  • Northeast Georgia Medical Center-Gainesville, Gainesville
  • e altri 2
In reclutamentoFase 3Volontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 31 mar 2026 · NCT07018869

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Northside Hospital, Atlanta
  • Northside Hospital - Duluth, Duluth
  • Liberty County Cancer Care, Hinesville
  • e altri 4
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06418204

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

  • Emory University, Atlanta
In reclutamentoFase 1/2
Età da 18 a 85 · Tutti i sessi · Aggiornato il 29 gen 2026 · NCT06055439

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • North Georgia Health System, Gainesville
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 40 e oltre · Tutti i sessi · Aggiornato il 20 gen 2026 · NCT05366881

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • Northside Hospital, Atlanta
  • Northeast Georgia Medical Center Braselton, Braselton
  • John B Amos Cancer Center, Columbus
  • e altri 8
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 gen 2026 · NCT06073431

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

  • John B Amos Cancer Center, Columbus
In reclutamentoStudio osservazionale
Età 60 e oltre · Tutti i sessi · Aggiornato il 8 gen 2026 · NCT03998202

A Web-Based Dyadic Intervention for Colorectal Cancer

  • Emory University/Winship Cancer Institute, Atlanta
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 dic 2025 · NCT05663203

A Beta-only IL-2 ImmunoTherapY Study

  • Emory - Winship Cancer Institute, Atlanta
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2025 · NCT05086692

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.